1. Munkongdee T, Chen P, Winichagoon P, Fucharoen S, Paiboonsukwong K. Update in Laboratory Diagnosis of Thalassemia. Front Mol Biosci. 2020 May 27;7:74. doi: 10.3389/fmolb.2020.00074. PMID: 32671092; PMCID: PMC7326097 [DOI:10.3389/fmolb.2020.00074] [PMID] []

2. Mahachoklertwattana P, Sirikulchayanonta V, Chuansumrit A, Karnsombat P, Choubtum L, Sriphrapradang A, et al. Bone histomorphometry in children and adolescents with beta-thalassemia disease: iron-associated focal osteomalacia. J Clin Endocrinol Metab. 2003 Aug;88(8):3966-72. doi: 10.1210/jc.2002-021548. PMID: 12915694. [DOI:10.1210/jc.2002-021548] [PMID]

3. Wong P, Fuller PJ, Gillespie MT, Milat F. Bone Disease in Thalassemia: A Molecular and Clinical Overview. Endocr Rev. 2016 Aug;37(4):320-46. doi: 10.1210/er.2015-1105. Epub 2016 Jun 16. PMID: 27309522. [DOI:10.1210/er.2015-1105] [PMID]

4. Yu U, Chen L, Wang X, Zhang X, Li Y, Wen F, et al,. Evaluation of the vitamin D and biomedical statuses of young children with β-thalassemia major at a single center in southern China. BMC Pediatr. 2019 Oct 23;19(1):375. doi: 10.1186/s12887-019-1744-8. PMID: 31646984; PMCID: PMC6813046. [DOI:10.1186/s12887-019-1744-8] [PMID] []

5. Toumba M, Skordis N. Osteoporosis syndrome in thalassaemia major: an overview. J Osteoporos. 2010 May 26;2010:537673. doi: 10.4061/2010/537673. PMID: 20976089; PMCID: PMC2957233. [DOI:10.4061/2010/537673] [PMID] []

6. Kanis JA. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos Int. 1994 Nov;4(6):368-81. doi: 10.1007/BF01622200. PMID: 7696835. [DOI:10.1007/BF01622200] [PMID]

7. Ehlers KH, Giardina PJ, Lesser ML, Engle MA, Hilgartner MW. Prolonged survival in patients with beta-thalassemia major treated with deferoxamine. J Pediatr. 1991 Apr;118(4 Pt 1):540-5. doi: 10.1016/s0022-3476(05)83374-8. PMID: 2007928. [DOI:10.1016/S0022-3476(05)83374-8] [PMID]

8. Shah S, N. Shah J, R. Vyas B. Assessment of bone mineral density in multi-transfused thalassemia patients in a tertiary care hospital. Pediatric Rev: int j pediatrics res;7(1):32-8. DOI: https://doi.org/10.17511/ijpr.2020.i01.06 [DOI:10.17511/ijpr.2020.i01.06.]

9. Angastiniotis M, Pavlides N, Aristidou K, Kanakas A, Yerakaris M, Eracleous E, et al,. Bone pain in thalassaemia: assessment of DEXA and MRI findings. J Pediatr Endocrinol Metab. 1998;11 Suppl 3:779-84. PMID: 10091146.

10. Moradvaeisi B, Rostami N, Derakhshan S, Roshani D. The frequency of osteoporosis and osteopenia in the paitents with beta thalassemia major and correlation of biochemical markers with bone densitometry results in these patients in Sanandaj. Scientific Journal of Kurdistan University of Medical Sciences. 2016 Dec 10;21(5):1-7.

11. Meena MC, Hemal A, Satija M, Arora SK, Bano S. Comparison of Bone Mineral Density in Thalassemia Major Patients with Healthy Controls. Adv Hematol. 2015;2015:648349. doi: 10.1155/2015/648349. Epub 2015 Dec 31. PMID: 26880923; PMCID: PMC4735999. [DOI:10.1155/2015/648349] [PMID] []

12. Hamidpour M, Jafari F, Mehrpouri M, Azarkyvan A, Bashash D, Maboudi AA. Evaluation of relationship between biochemical parameters and osteoporosis in patients with β-thalassemia major. Iran J Ped Hematol Oncol. 2022; 12(1): 41-48 DOI: https://doi.org/10.18502/ijpho.v12i1.8360 [DOI:10.18502/ijpho.v12i1.8360.]

13. Nakavachara P, Weerakulwattana P, Pooliam J, Viprakasit V. Bone mineral density in primarily preadolescent children with hemoglobin E/β-thalassemia with different severities and transfusion requirements. Pediatr Blood Cancer. 2022 Sep;69(9):e29789. doi: 10.1002/pbc.29789. Epub 2022 Jun 2. PMID: 35652568. [DOI:10.1002/pbc.29789] [PMID]

14. Lewiecki EM, Watts NB, McClung MR, Petak SM, Bachrach LK, Shepherd JA, et al,. International Society for Clinical Densitometry. Official positions of the international society for clinical densitometry. J Clin Endocrinol Metab. 2004 Aug;89(8):3651-5. doi: 10.1210/jc.2004-0124. PMID: 15292281. [DOI:10.1210/jc.2004-0124] [PMID]

15. Bordbar M, Omrani GR, Haghpanah S, Saki F, Karimi M, Zekavat O. Bone mineral density in transfusion-dependent thalassemia patients and its associated factors in Southern Iran. Arch Osteoporos. 2020 Sep 21;15(1):148. doi: 10.1007/s11657-020-00811-7. PMID: 32955681. [DOI:10.1007/s11657-020-00811-7] [PMID]

16. Piriyakhuntorn P, Tantiworawit A, Phimphilai M, Srichairatanakool S, Teeyasoontranon W, Rattanathammethee T, et al. Prevalence and risk factors of low bone mineral density and fractures of young thalassemia patients. Blood. 2018 Nov 29;132:3636. https://doi.org/10.1182/blood-2018-99-113465 [DOI:10.1182/blood-2018-99-113465.]

17. Mahmoodi Nesheli H, Farahanian E. Relation between bone mineral density and serum ferritin levels in patients with thalassemia major. Caspian J Pediatr Sep 2016; 2(2): 158-63.

18. Zarei T, Haghpanah S, Parand S, Moravej H, Dabbaghmanesh MH, Omrani GR, et al. Evaluation of bone mineral density in patients with hemoglobin H disease. Ann Hematol. 2016 Aug;95(8):1329-32. doi: 10.1007/s00277-016-2708-9. Epub 2016 Jun 3. PMID: 27256348. [DOI:10.1007/s00277-016-2708-9] [PMID]

19. De Sanctis V, Soliman AT, Elsedfy H, Yassin M, Canatan D, Kilinc Y, et al. I-CET (International Network on Growth Disorders and Endocrine Complications in Thalassemia). Osteoporosis in thalassemia major: an update and the I-CET 2013 recommendations for surveillance and treatment. Pediatr Endocrinol Rev. 2013 Dec;11(2):167-80. PMID: 24575552.

20. Voskaridou E, Terpos E. Pathogenesis and management of osteoporosis in thalassemia. Pediatr Endocrinol Rev. 2008 Oct;6 Suppl 1:86-93. PMID: 19337161.

21. Vogiatzi MG, Macklin EA, Fung EB, Cheung AM, Vichinsky E, Olivieri N, et al. Thalassemia Clinical Research Network. Bone disease in thalassemia: a frequent and still unresolved problem. J Bone Miner Res. 2009 Mar;24(3):543-57. doi: 10.1359/jbmr.080505. PMID: 18505376; PMCID: PMC3276604. [DOI:10.1359/jbmr.080505] [PMID] []

22. Gaudio A, Morabito N, Catalano A, Rapisarda R, Xourafa A, Lasco A. Pathogenesis of Thalassemia Major-associated Osteoporosis: A Review with Insights from Clinical Experience. J Clin Res Pediatr Endocrinol. 2019;11(2):110-117. doi:10.4274/jcrpe.galenos.2018.2018.0074 [DOI:10.4274/jcrpe.galenos.2018.2018.0074] [PMID] []

23. Manolopoulos PP, Lavranos G, Mamais I, Angouridis A, Giannakou K, Johnson EO. Vitamin D and bone health status in beta thalassemia patients-systematic review. Osteoporos Int. 2021 Jun;32(6):1031-1040. doi: 10.1007/s00198-021-05821-w. Epub 2021 Jan 9. PMID: 33423084. [DOI:10.1007/s00198-021-05821-w] [PMID]

24. Thiagarajan NR, Kumar CGD, Sahoo J, Krishnamurthy S. Effect of Vitamin D and Calcium Supplementation on Bone Mineral Content in Children with Thalassemia. Indian Pediatr. 2019 Apr 15;56(4):307-310. PMID: 31064900. [DOI:10.1007/s13312-019-1520-8] [PMID]

25. Valizadeh N, Farrokhi F, Alinejad V, Said Mardani S, Valizadeh N, Hejazi S, et al. Bone density in transfusion dependent thalassemia patients in Urmia, Iran. Iran J Ped Hematol Oncol. 2014;4(2):68-71. Epub 2014 Apr 20. PMID: 25002928; PMCID: PMC4083203.

26. Baldini M, Marcon A, Ulivieri FM, Seghezzi S, Cassin R, Messina C, et al. Bone quality in beta-thalassemia intermedia: relationships with bone quantity and endocrine and hematologic variables. Ann Hematol. 2017 Jun;96(6):995-1003. doi: 10.1007/s00277-017-2959-0. Epub 2017 Mar 20. PMID: 28321531. [DOI:10.1007/s00277-017-2959-0] [PMID]

27. Meloni A, Pistoia L, Maffei S, Ricchi P, Casini T, Corigliano E, et al. Bone status and HCV infection in thalassemia major patients. Bone. 2023 Apr;169:116671. doi: 10.1016/j.bone.2023.116671. Epub 2023 Jan 6. PMID: 36623757. [DOI:10.1016/j.bone.2023.116671] [PMID]

28. Piriyakhuntorn P, Tantiworawit A, Phimphilai M, Srichairatanakool S, Teeyasoontranon W, Rattanathammethee T, et al. Prevalence and risk factors of low bone mineral density and fractures of young thalassemia patients. Blood. 2018 Nov 29;132:3636.http://dx.doi.org/10.1182/blood-2018-99-113465. [DOI:10.1182/blood-2018-99-113465]

29. Alexiou E, Diamantidis M, Vassiou K, Fezoulidis I, Vlychou M. Dual X Ray absorptiometry is superior in detecting bone mineral density alterations in adult patients with thalassaemia major compared to quantitative computed tomography. Hellenic Journal οf Radiology. 2021 Dec 28;6(4).

30. Karimi M, Ghiam AF, Hashemi A, Alinejad S, Soweid M, Kashef S. Bone mineral density in beta-thalassemia major and intermedia. Indian Pediatr. 2007 Jan;44(1):29-32. PMID: 17277428.

31. Shamshirsaz AA, Bekheirnia MR, Kamgar M, Pourzahedgilani N, Bouzari N, Habibzadeh M, et al. Metabolic and endocrinologic complications in beta-thalassemia major: a multicenter study in Tehran. BMC Endocr Disord. 2003 Aug 12;3(1):4. doi: 10.1186/1472-6823-3-4. PMID: 12914670; PMCID: PMC194672. [DOI:10.1186/1472-6823-3-4] [PMID] []

32. Mohajeri-Tehrani MR, Darvishian N, Arab F, Salemkar S, Mohseni F, Larijani B, Hamidi Z. The role of using different reference population in the prevalence of low BMD in the thalassemia patients. J Diabetes Metab Disord. 2019 Nov 14;19(1):431-435. doi: 10.1007/s40200-019-00455-6. Erratum in: J Diabetes Metab Disord. 2019 Dec 23;19(1):663. PMID: 32550194; PMCID: PMC7270311. [DOI:10.1007/s40200-019-00455-6] [PMID] []

33. Farmakis D, Porter J, Taher A, Domenica Cappellini M, Angastiniotis M, Eleftheriou A. 2021 Thalassaemia International Federation Guidelines for the Management of Transfusion-dependent Thalassemia. Hemasphere. 2022 Jul 29;6(8):e732. doi: 10.1097/HS9.0000000000000732. PMID: 35928543; PMCID: PMC9345633. [DOI:10.1097/HS9.0000000000000732] [PMID] []